Angeles Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$49.9K Hold
237
– – ﹤0.01% 536
2026
Q2
$45.1K Buy
237
+30
+14% +$5.16K ﹤0.01% 572
2026
Q1
$35K Hold
207
– – ﹤0.01% 480
2025
Q4
$34.9K Buy
207
+183
+763% +$29.7K ﹤0.01% 427
2025
Q3
$3.46K Hold
24
– – ﹤0.01% 405
2025
Q2
$3.04K Sell
24
-500
-95% -$61.4K ﹤0.01% 423
2025
Q1
$67K Hold
524
– – 0.01% 320
2024
Q4
$69.3K Buy
524
+500
+2,083% +$70.3K 0.01% 331
2024
Q3
$3.49K Hold
24
– – ﹤0.01% 326
2024
Q2
$3.29K Buy
+24
New +$3.2K ﹤0.01% 301

Other funds holding IBB

Angeles Wealth Management's IBB Position: Q3 2026 in Review

Angeles Wealth Management held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 237 shares worth $49.9K. The position accounts for ﹤0.01% of the portfolio, ranked #536.

Angeles Wealth Management first reported a position in IBB in Q2 2024 and has held it in 10 quarters since. The position peaked at $69.3K in Q4 2024. 1,030 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Angeles Wealth Management held 237 shares of iShares Biotechnology ETF worth $49.9K as of Q3 2026.
  • Angeles Wealth Management left its iShares Biotechnology ETF share count unchanged in Q3 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Angeles Wealth Management's portfolio in Q3 2026, its #536 holding.
  • Angeles Wealth Management first reported a position in iShares Biotechnology ETF in Q2 2024 and has held it in 10 quarters since.
  • Angeles Wealth Management's iShares Biotechnology ETF position peaked at $69.3K in Q4 2024.
  • 1,030 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Angeles Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.